What gastrointestinal condition is treated with sulfasalazine?

• A. Gastroesophageal reflux disease
• B. Ulcerative colitis
• C. Chronic constipation
• D. Peptic ulcer disease

Answer: (B)

Sulfasalazine is primarily utilized in the treatment of ulcerative colitis, which is a form of inflammatory bowel disease (IBD) characterized by inflammation and ulceration of the colon. The drug works by inhibiting the production of inflammatory mediators in the gut and has both anti-inflammatory and immunosuppressive properties.

In the case of ulcerative colitis, sulfasalazine helps to reduce bowel inflammation and maintain remission in patients. It is particularly beneficial in active disease and for preventing flare-ups. This makes it a cornerstone therapy for managing ulcerative colitis, setting it apart from the other conditions listed.

The other options, while involving gastrointestinal issues, are not primarily treated with sulfasalazine. Gastroesophageal reflux disease focuses on symptoms related to stomach acid moving up into the esophagus, chronic constipation is typically managed with dietary modifications and laxatives, and peptic ulcer disease is treated with proton pump inhibitors and antibiotics when caused by H. pylori infection. Therefore, the specificity and mechanism of action of sulfasalazine align closely with the treatment needs of ulcerative colitis.